{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "20020 Diagnosis & management of Kawasaki disease 1.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "20020"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP)"
                    },
                    {
                        "text": "Guideline"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All Paediatric and"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "24 November 2020"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "23 November 2023"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "NICE Recommendation NG143/8"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Women's and Children's"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Dr Ari Das, Paediatric Consultant, Dr Sucharita Ghosh, Paediatric Registrar Dr Khayathiri Sundaralingham , Paediatric Registrar"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2610 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2612 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "Paediatric Practice Steering Group"
                    },
                    {
                        "text": "22September 2020"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Dr Cyriac, Paediatric Consultant"
                    },
                    {
                        "text": "14 July 2020"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "20 October 2020"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Joint Document Management Group)"
                    },
                    {
                        "text": "November 2020"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet \u2610Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "20020 Diagnosis & management of Kawasaki disease 1.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 17,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Consulted With: this must include Pharmacy if the document has any reference to medication"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Dr Agrawal"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "19 May 2020"
                    },
                    {
                        "text": "Dr Annam"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "19 May 2020"
                    },
                    {
                        "text": "Dr Chavakula"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "19 May 2020"
                    },
                    {
                        "text": "Dr Hassan"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "19 May 2020"
                    },
                    {
                        "text": "Dr Lethaby"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "19 May 2020"
                    },
                    {
                        "text": "Dr Lim"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "19 May 2020"
                    },
                    {
                        "text": "Dr Nambiar"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "19 May 2020"
                    },
                    {
                        "text": "Dr Ottayil"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "19 May 2020"
                    },
                    {
                        "text": "Dr Pradeep"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "19 May 2020"
                    },
                    {
                        "text": "Dr Srinivasagam"
                    },
                    {
                        "text": "Paediatric Consultant"
                    },
                    {
                        "text": "19 May 2020"
                    },
                    {
                        "text": "Dr Thomas"
                    },
                    {
                        "text": "Associate Specialist"
                    },
                    {
                        "text": "19 May 2020"
                    },
                    {
                        "text": "Lucy Horsman"
                    },
                    {
                        "text": "Ward Manager"
                    },
                    {
                        "text": "19 May 2020"
                    },
                    {
                        "text": "Angela Poulter"
                    },
                    {
                        "text": "Ward Manager"
                    },
                    {
                        "text": "19 May 2020"
                    },
                    {
                        "text": "Mary Stebbens"
                    },
                    {
                        "text": "Clinical Facilitator"
                    },
                    {
                        "text": "19 May 2020"
                    },
                    {
                        "text": "Jo Hennessey"
                    },
                    {
                        "text": "Clinical Facilitator"
                    },
                    {
                        "text": "19 May 2020"
                    },
                    {
                        "text": "Claire Fitzgerald"
                    },
                    {
                        "text": "Pharmacist"
                    },
                    {
                        "text": "19 May 2020"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "(Refer to the main body of the text) 04071 Policy for standard infection prevention precautions 11046 Children and young people (CYP) observation policy 10043 Feverish illness in children: assessment and initial management in children younger than 5 years 09065 Preparing and administering intravenous infusions of drugs for children and young people 17003 Children's Emergency Department SOP"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/ Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Dr Das, Dr Ghosh and Dr Khayathiri"
                    },
                    {
                        "text": "Newly created to prompt clinicians to think about Kawasaki's Disease with fewer clinical features to reduce the number of children with long term cardiac complications."
                    },
                    {
                        "text": "24 November 2020"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 7,
            "data": {
                "is_heading": 1,
                "text": "Contents"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 8,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Introduction ................................................................................................................. 4  Roles and Responsibilities.........................................................................................4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Signs and Symptoms ................................................................................................. 4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Physical Examination ................................................................................................. 6"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Complications ............................................................................................................. 7"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Investigations.............................................................................................................. 7"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Management ................................................................................................................ 8"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Management of Kawasaki Disease diagnosed after the first 10 days .................. 10"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Follow up and Long Term Management ................................................................. 11 10 Prognosis .................................................................................................................. 11 11 Staff and Training ..................................................................................................... 11  Equality Impact Assessment\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.....12  Approval and Implementation\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.\u2026..12 References\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026......12 Appendix 1: Clinical Manifestations of Kawasaki Disease .......................................... 13 Appendix 2: Preliminary Equality Analysis\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u202614"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 0,
                "text": "Diagnosis and management of Kawasaki Disease / 20020 / 1.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Page  of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "This guideline is to give direction to the management and follow up of Children suspected to have Kawasaki Disease (KD)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 0,
                "prefix": 1967.0,
                "text": "The other name for Kawasaki Disease is mucocutaneous lymph node syndrome. It was first described in Japan in It is a symptom complex arising secondary to an acute vasculitis and is a leading cause of acquired heart disease in children."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 21,
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "It is a rare disease, but the commonest cause of vasculitis in children leading to coronary heart disease."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 22,
            "data": {
                "is_heading": 0,
                "prefix": 1.4,
                "text": "Kawasaki Disease has been described on every continent and across all races and ethnicities. Incidence varies considerably worldwide 3.4 to 100 per 100,000 children."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Roles and responsibilities"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "The Specialist Nurse for Guidelines and Audit is responsible for ensuring clinical policies, guidelines and SOPs, are evidence-based and developed in line with national guidelines and following appropriate consultation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 0,
                "prefix": 2.2,
                "text": "The clinical director is responsible for the implementation of this guideline within the directorate."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 0,
                "prefix": 2.3,
                "text": "The Head of Nursing and Quality for Children and Young People, and Ward managers are responsible for ensuring paediatric staff are aware of the guideline and implement it."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 27,
            "data": {
                "is_heading": 0,
                "prefix": 2.4,
                "text": "The Paediatric Clinical Director and the Lead Consultant for Children with renal complications are responsible for ensuring the implementation of this guideline within the clinical setting."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 0,
                "prefix": 2.5,
                "text": "All paediatric staff are responsible for ensuring they are familiar with this guideline in relation to their practice and have the appropriate skills to implement this guideline."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Signs and symptoms"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 0,
                "prefix": 3.1,
                "text": "There are three types of Kawasaki Disease described."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 1,
                "prefix": 3.2,
                "text": "Classical Kawasaki disease"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 32,
            "data": {
                "is_heading": 0,
                "text": "3.2.1 Presence of fever for at least *5 days with at least four of the following clinical features:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 0,
                "text": "Mucositis: That is erythema and cracking of lips, strawberry tongue and/or erythema of oral and pharyngeal mucosa."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 0,
                "text": "Bilateral bulbar conjunctival injection without discharge/exudates"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 0,
                "text": "Rash: maculopapular, diffuse erythroderma or Erythema multiforme like"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 0,
                "text": "Erythema and oedema of the hands and feet in acute phase and or periungal desquamation in subacute phase."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 0,
                "text": "Cervical lymphadenopathy (more than or equal to 1.5 cm diameter). Usually unilateral"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 38,
            "data": {
                "is_heading": 0,
                "text": "*The diagnosis can be made with 4 days of fever when at least 4 principal clinical features (particularly redness and swelling of the hands and feet) are present. *Kawasaki Disease to be also considered even if fever resolves after 7days if the patient has or had features fulfilling clinical criteria and supportive investigations."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 39,
            "data": {
                "is_heading": 1,
                "prefix": 3.3,
                "text": "Incomplete Kawasaki Disease"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 0,
                "text": "3.3.1 A diagnosis of incomplete Kawasaki Disease should be considered when,"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 0,
                "text": "Children with fever for 5 days or more plus 2 or 3 principal clinical features"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 0,
                "text": "There is prolonged fever and irritability in infants (especially under 6months of age) or older children and adolescents."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 0,
                "text": "Infants with prolonged fever and unexplained aseptic meningitis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 0,
                "text": "Infants or children with prolonged fever and cervical lymphadenitis unresponsive to antibiotic therapy"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 0,
                "text": "Patients who lack full clinical features of classic KD are often evaluated for incomplete KD. If coronary artery abnormalities are detected, the diagnosis of KD is considered confirmed in most cases."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 1,
                "prefix": 3.4,
                "text": "Resistant Kawasaki Disease"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 0,
                "text": "3.4.1  This diagnosis is made after failure of initial treatment. Fever continues beyond 36 hours after treatment is started. Prognosis is different in this group as they are prone to Coronary artery disease."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Physical examination"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "Clinical suspicion and awareness of this disease entity is essential followed by examination for physical signs of this disease."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 1,
                "prefix": 0.0,
                "text": "Fever: Presence of fever usually over  c, lasting for minimum of 5 day and even up to 7 days .It typically rises and falls with no predictable pattern."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 1,
                "text": "Mucositis: Cracking of lips with inflammation in the oral and pharyngeal mucosa, strawberry tongue ( a red bumpy tongue with enlarged taste buds resembling a strawberry, occasionally the tongue will be white before turning red like a strawberry or raspberry)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 1,
                "text": "Conjunctivitis: The bulbar and palpebral conjunctiva look inflamed but there is no purulent discharge and it is painless"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 1,
                "text": "Rash: It is a polymorphous exanthema: It may be morbiliform (measles-like), maculopapular (red patches and bumps), just erythematous (red skin) or target like (Erythema multiforme like) and may be persistent over days or an evanescent rash that appears only during periods of fever and disappears as the temperature normalises. It is usually extensive with involvement of the trunk and extremities with accentuation in the perianal region."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 1,
                "text": "Hands and feet: Erythema and oedema of the hands and feet are noted in the acute phase and or periungal desquamation in the sub-acute phase."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 1,
                "text": "Cervical Lymphadenopathy: Greater than or equal to 1.5cm - usually unilateral. Is usually associated with retropharyngeal wall oedema, lateral cervical wall oedema and nasopharyngeal wall oedema."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 56,
            "data": {
                "is_heading": 1,
                "text": "Less common symptoms /signs (complications)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 57,
            "data": {
                "is_heading": 0,
                "text": "Neurological: extreme irritability, aseptic meningitis, sensorineural hearing loss-which is transient during acute phase."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 58,
            "data": {
                "is_heading": 0,
                "text": "Musculoskeletal: arthritis, arthralgia, myositis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 0,
                "text": "GIT: Diarrhoea, vomiting, hepatitis, abdominal pain, acute distention of gallbladder (during first two weeks of illness, identified by US)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 0,
                "text": "Genitourinary: urethritis, sterile pyuria"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 61,
            "data": {
                "is_heading": 0,
                "text": "Others: Erythema, induration of BCG inoculation site, mild anterior uveitis (needs"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 62,
            "data": {
                "is_heading": 0,
                "text": "slit lamp examination)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 63,
            "data": {
                "is_heading": 1,
                "prefix": 4.2,
                "text": "Causes: The precise aetiology is unknown. Aberrant inflammation which predominately affects medium-sized blood vessels results in coronary artery aneurysms; hence the aim of treatment is to bring down the inflammation to stop long term cardiac complications. Several triggers, including Epstein-Barr virus and super- antigens from staphylococcus and streptococcus species have been suggested."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 64,
            "data": {
                "is_heading": 1,
                "prefix": 4.3,
                "text": "Differential diagnosis: Many childhood diseases may be confused with Kawasaki Disease"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 65,
            "data": {
                "is_heading": 0,
                "text": "Group A streptococcal infection +/- toxin mediated disease"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 66,
            "data": {
                "is_heading": 0,
                "text": "Staphylococcus aureus infection +/-toxin mediated disease"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 67,
            "data": {
                "is_heading": 0,
                "text": "Viral infections- Adenovirus, enterovirus, measles, EBV"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 68,
            "data": {
                "is_heading": 0,
                "text": "Drug hypersensitivity reactions, including Stevens Johnson syndrome"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 69,
            "data": {
                "is_heading": 0,
                "text": "Systemic juvenile idiopathic arthritis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 70,
            "data": {
                "is_heading": 0,
                "prefix": 4.4,
                "text": "However with careful attention to evaluation of the clinical picture and response to antibiotics the diagnosis is likely to be apparent. The inflammatory markers are persistently elevated with no other explanation in patients with Kawasaki Disease."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 71,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Complications"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 72,
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Serious complications are rare 5.1.1In the acute phase (<10 days)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 73,
            "data": {
                "is_heading": 0,
                "text": "Myocarditis +/- endocarditis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 74,
            "data": {
                "is_heading": 0,
                "text": "Pericarditis +/- effusion/tamponade"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 75,
            "data": {
                "is_heading": 0,
                "text": "Valvular incompetence"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 76,
            "data": {
                "is_heading": 0,
                "text": "5.1.2 In the sub-acute phase (>10 days)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 77,
            "data": {
                "is_heading": 0,
                "text": "Coronary artery vasculitis- dilatation +/- aneurysm. First detectable usually after 10 days, with peak onset at 2-4 weeks."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 78,
            "data": {
                "is_heading": 0,
                "text": "Coronary artery thrombosis and stenosis."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 79,
            "data": {
                "is_heading": 0,
                "text": "Systemic large vessel vasculitis (1-2% cases)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 80,
            "data": {
                "is_heading": 0,
                "text": "Cerebral circulation \u2013 thrombotic stroke"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 81,
            "data": {
                "is_heading": 0,
                "text": "Subclavian, axillary, brachial aneurysms"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 82,
            "data": {
                "is_heading": 0,
                "text": "Peripheral ischaemia/gangrene"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 83,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Investigations"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 84,
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "Kawasaki Disease has no confirmatory laboratory findings."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 85,
            "data": {
                "is_heading": 0,
                "text": "Inflammatory markers: elevated ESR, CRP and white cell count, platelet count (Usually in the second week)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 86,
            "data": {
                "is_heading": 0,
                "text": "In case of incomplete Kawasaki disease a decision to treat may be aided by the following list of investigations:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 87,
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "FBC: may show mild anaemia, leucocytosis with neutrophilia and immature forms, thrombocytosis after week 1, peaks in the rd week, normalizes by 4-8"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 88,
            "data": {
                "is_heading": 0,
                "text": "weeks; \uf0b7  Raised inflammatory markers like CRP, ESR etc;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 89,
            "data": {
                "is_heading": 0,
                "text": "U&E, LFT, Plasma lipid profile: hyponatremia, hypalbuminaemia, elevated serum transaminases, elevated Gamma glutamyl trans peptidase, abnormal plasma lipids;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 90,
            "data": {
                "is_heading": 0,
                "text": "Raised Troponin I;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 91,
            "data": {
                "is_heading": 0,
                "text": "Urine microscopy and culture: Sterile pyuria;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 92,
            "data": {
                "is_heading": 0,
                "text": "Others: Pleocytosis of cerebro spinal fluid;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 93,
            "data": {
                "is_heading": 0,
                "text": "To exclude other diagnosis: ASOT and anti-DNase B, Blood culture, nose/throat/skin swab, lumbar puncture, coagulation screen, ANA, rheumatoid factor, ferritin. Serology for EBV, mycoplasma, CMV, parvovirus, measles. Stool for enterovirus;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 94,
            "data": {
                "is_heading": 0,
                "text": "FOR Connective tissue vasculitis: C3/C4, ANA/ANCA, significantly raised ferritin;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 95,
            "data": {
                "is_heading": 0,
                "text": "US abdomen: for hydrops of gall bladder;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 96,
            "data": {
                "is_heading": 0,
                "text": "LDH, VMAs: To consider malignancy and consult with Haem/Oncology for need of BM examination;"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 97,
            "data": {
                "is_heading": 1,
                "prefix": 6.2,
                "text": "Echocardiography:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 98,
            "data": {
                "is_heading": 0,
                "text": "This is not a diagnostic test for Kawasaki Disease. Aneurysm formation is a complication of the disease process and treatment should not be delayed in case of clinical suspicion. In the first week of the disease echo may reveal LV dysfunction, valvular abnormality or pericardial effusion."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 99,
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "If positive for coronary artery aneurysm (usually in the nd week of the disease), repeat echo need to be done to monitor progression"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 100,
            "data": {
                "is_heading": 0,
                "text": "6-8 weeks from onset. If there is no aneurysm at this stage and inflammatory markers have normalised, further echo is not required. (Archives of disease in childhood, January 2020, Vol 105, Issue1)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 101,
            "data": {
                "is_heading": 0,
                "text": "12 months from onset and yearly to monitor the regression/progression of aneurysm."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 102,
            "data": {
                "is_heading": 1,
                "prefix": 6.3,
                "text": "Electrocardiography"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 103,
            "data": {
                "is_heading": 0,
                "text": "ECG at presentation may show: Prolonged PR interval, nonspecific ST and T wave changes and arrhythmias. An ECG should always be performed with children with Kawasaki syndrome."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 104,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Management"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 105,
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "Children should be reviewed by Consultant before starting definite treatment for Kawasaki Disease."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 106,
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "The aim of treatment is to bring down the inflammation to prevent complications of coronary artery disease."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 107,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Treatment should be started as soon as the diagnosis is confirmed, ideally within  days of onset of symptoms. Treatment is more effective if commenced before 7 days. Treatment can be started beyond 10 days as well in the presence of ongoing signs (+/- laboratory evidence) of inflammation.7.4 First line treatment:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 108,
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "7.4.1 IVIG (Intravenous immunoglobulin) is the main stay of treatment. Dose:  2gm/kg given over  hours.  If there are features of heart failure (disproportionate tachycardia, gallop rhythm, liver enlargement, breathlessness) the rate needs to be adjusted after discussion with consultant.( Consent forms not required, record batch number and product name in notes, different manufacturers have specific infusion rates, local request form for immunoglobulin needs to be completed)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 109,
            "data": {
                "is_heading": 1,
                "text": "Reactions to IVIG: IVIG can trigger haemolysis. This is batch and brand-dependent (There are reports with Privigen \u2013 do NOT use Privigen for Kawasaki's disease)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 110,
            "data": {
                "is_heading": 0,
                "text": "Caution: Do not use ESR to monitor disease progress after IVIG, because of falsely elevated results."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 111,
            "data": {
                "is_heading": 1,
                "text": "7.4.2 High dose Aspirin: High dose is initially prescribed, dose 7.5mg to 12.5mg/kg four times a day for two weeks or until at least 48 to 72 hours after cessation of fever."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 112,
            "data": {
                "is_heading": 1,
                "text": "7.4.3 Low dose Aspirin: Once the inflammation is settled reduce to dose of Aspirin to 3- 5mg/kg/ as single daily dose. This lower dose is for its anti-platelet activity which is continued till the patient has the final echo confirming the absence of coronary artery abnormalities."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 113,
            "data": {
                "is_heading": 1,
                "prefix": 7.5,
                "text": "Second line treatment:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 114,
            "data": {
                "is_heading": 0,
                "prefix": 36.0,
                "text": "7.5.1 If patient has not responded to Initial IVIG, defined as persistent fever>  hours after completion of IVIG infusion."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 115,
            "data": {
                "is_heading": 1,
                "text": "7.5.2 Do consider discussing the case with tertiary team infectious diseases team at Great Ormond Street or St. Mary's if patient has not responded to first line treatment."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 116,
            "data": {
                "is_heading": 1,
                "text": "Repeat IVIG 2gms/kg as a single infusion over 10-12 hours."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 117,
            "data": {
                "is_heading": 1,
                "prefix": 30.0,
                "text": "Corticosteroids: as IV Methylprednisolone 10mg/kg ( max  mg) over 2-3 hours once daily for 3 days, followed by Oral Prednisolone 2mg/kg to be weaned over 2-3 weeks ( a longer duration of weaning)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 118,
            "data": {
                "is_heading": 1,
                "text": "Infliximab can be used in place of corticosteroids(Archives of disease in childhood, January 2020, Vol 105, Issue1)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 119,
            "data": {
                "is_heading": 1,
                "prefix": 7.6,
                "text": "Supportive treatment:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 120,
            "data": {
                "is_heading": 0,
                "text": "Fluid balance to be maintained"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 121,
            "data": {
                "is_heading": 1,
                "text": "Regular anti-pyretics, all NSAIDs to be stopped when Aspirin is commenced"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 122,
            "data": {
                "is_heading": 0,
                "text": "Consider Omeprazole (PPIs) when Aspirin and oral steroids are used."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 123,
            "data": {
                "is_heading": 0,
                "prefix": 11.0,
                "text": "As we are not a cardiac unit this is not particularly applicable. We will be guided by the cardiac team if there are cardiac abnormalities. Vaccination should be deferred for 3 months ( AHA 2017 guidelines indicate  months deferment)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 124,
            "data": {
                "is_heading": 1,
                "prefix": 7.7,
                "text": "Indicators of good response to 1st-line treatment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 125,
            "data": {
                "is_heading": 1,
                "text": "ALL aspects should be satisfied:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 126,
            "data": {
                "is_heading": 0,
                "text": "Improved clinical state (irritability, other clinical features improving, reducing signs of inflammation e.g. redness)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 127,
            "data": {
                "is_heading": 0,
                "prefix": 24.0,
                "text": "Fever improves \u2013 often within a few hours. On-going fevers >38\u02daC more than  hours after IVIG may suggest treatment failure"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 128,
            "data": {
                "is_heading": 0,
                "text": "CRP progressively falls"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 129,
            "data": {
                "is_heading": 1,
                "prefix": 7.8,
                "text": "High Risk disease"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 130,
            "data": {
                "is_heading": 0,
                "text": "Less than 1 year old and greater than 5 years"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 131,
            "data": {
                "is_heading": 0,
                "text": "Persistently High Inflammatory Markers"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 132,
            "data": {
                "is_heading": 0,
                "text": "Low albumin"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 133,
            "data": {
                "is_heading": 0,
                "text": "Features of shock or HLH"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 134,
            "data": {
                "is_heading": 0,
                "text": "Already evidence of aneurysms or coronary disease"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 135,
            "data": {
                "is_heading": 0,
                "text": "Failed IVIG"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 136,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Management of Kawasaki Disease diagnosed after the first  days"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 137,
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "If Kawasaki Disease is diagnosed after the acute phase (e.g. when there is skin peeling, or when fever and other symptoms have subsided) arrange bloods, urgent ECHO. If inflammatory markers (CRP, WBC and ESR are still elevated commence IVIG and aspirin as for primary treatment."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 138,
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "If there is no evidence of active inflammation and the child remains afebrile, the child should receive low dose Aspirin and routine echocardiography follow-up. There is no evidence that IVIG is of benefit to patients who have already developed aneurysms once inflammation has resolved"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 139,
            "data": {
                "is_heading": 1,
                "prefix": 8.3,
                "text": "Cardiac Referrals"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 140,
            "data": {
                "is_heading": 0,
                "text": "Our preferred cardiac centre is Royal Brompton Hospital. The initial scans are generally performed by our paediatricians with cardiology interest (Dr J Cyriac, Dr M Babu). These babies need to be referred to Brompton cardiac team for final scan and further management. All the babies awaiting the second scan at Brompton, preferably at 8 weeks, should be on low dose Aspirin. Cardiologists or paediatrician"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 141,
            "data": {
                "is_heading": 0,
                "text": "with interest in cardiology will make final decision of discontinuation of low dose Aspirin based on the echocardiogram findings."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 142,
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Follow-up and long term management"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 143,
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "Patients diagnosed with Kawasaki Disease need to meet the criteria below to enable a safe discharge from the hospital:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 144,
            "data": {
                "is_heading": 0,
                "prefix": 36.0,
                "text": "hours or more has elapsed since the completion of IVIG"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 145,
            "data": {
                "is_heading": 0,
                "text": "Fever has settled ( less than 37.5 for at least 24 hrs)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 146,
            "data": {
                "is_heading": 0,
                "text": "There are no other active signs of inflammation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 147,
            "data": {
                "is_heading": 0,
                "text": "Aspirin is tolerated well orally"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 148,
            "data": {
                "is_heading": 0,
                "text": "The child's family understands the regime of Aspirin t/t"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 149,
            "data": {
                "is_heading": 0,
                "text": "Family understands the need for repeat prescription of Aspirin from GP"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 150,
            "data": {
                "is_heading": 0,
                "text": "EDL includes advice on deferring vaccines after use of IVIG."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 151,
            "data": {
                "is_heading": 0,
                "text": "KD related maculopathy is characterized by myointimal proliferation with or without layering of thrombus which may lead to progressive coronary artery stenosis. This may lead to ischemia, infarction and sudden death. This will need lifelong follow up."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 152,
            "data": {
                "is_heading": 1,
                "text": "Regular anti-pyretics, all NSAIDs to be stopped when Aspirin is commence"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 153,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Prognosis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 154,
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "About 10% of children have resistant Type of Kawasaki disease and coronary artery disease and their complication and will need lifelong follow up. It is essential that each case of diagnosed/treated case of Kawasaki disease be referred to a Paediatric Cardiologist for follow up, to avoid long term damages of Coronary artery disease. Timely treatment can avoid this. If after treatment with IVIG there is no evidence of coronary aneurysm and inflammatory markers are down, child doesn't need follow up. (Archives of disease in childhood, January 2020, Vol 105, and Issue1), this decision will be made by Cardiologists."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 155,
            "data": {
                "is_heading": 1,
                "prefix": 10.2,
                "text": "Cardiac Referrals"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 156,
            "data": {
                "is_heading": 0,
                "text": "Our preferred cardiac centre is Royal Brompton Hospital. The initial scans are generally performed by our paediatricians with cardiology interest (Dr J Cyriac, Dr M Babu). These babies need to be referred to Brompton cardiac team for final scan and further management."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 157,
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Staffing and Training"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 158,
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "All paediatric medical and nursing staff are to ensure that their knowledge and skills  are up-to-date in order to complete their portfolio for appraisal."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 159,
            "data": {
                "is_heading": 1,
                "prefix": 11.3,
                "text": "Guideline Management"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 160,
            "data": {
                "is_heading": 0,
                "text": "11.3.1 As an integral part of the knowledge, skills framework, staff are appraised annually to ensure competency in computer skills and the ability to access the current approved guidelines via the Trust's intranet site."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 161,
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Equality impact assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 162,
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "Mid and South Essex NHS Foundation Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 163,
            "data": {
                "is_heading": 0,
                "text": "(Refer to Appendix 1)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 164,
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Approval and implementation"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 165,
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "All policies, procedures and guidelines will be approved locally by the Paediatric Practice Steering Group prior to submission to the Controlled Document team for ratification by the Joint Document Management Group."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 166,
            "data": {
                "is_heading": 0,
                "prefix": 13.2,
                "text": "It is the Guidelines and Audit Nurse's and author's responsibility to inform the Paediatric Practice Steering Group and appropriate staff of the approved policy documents when they are uploaded to the Trust's Intranets."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 167,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "References"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 168,
            "data": {
                "is_heading": 0,
                "text": "(Archives of disease in childhood, January 2020, Vol 105, Issue1). References at the end"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 169,
            "data": {
                "is_heading": 0,
                "text": "Archives of disease in childhood, January 2020, Vol 105, Issue1"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 170,
            "data": {
                "is_heading": 0,
                "text": "PIER (Paediatric Innovation, Education and Research Network)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 171,
            "data": {
                "is_heading": 0,
                "text": "Eleftheriou, D., Levin, M., Shingadia, D., Tulloh, R., Klein, N. J., & Brogan, P. A. (2014). Management of Kawasaki disease. Archives of disease in childhood, 99(1), 74-83."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 172,
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: Clinical Manifestations of Kawasaki Disease"
            }
        },
        {
            "type": "image",
            "sequence_num": 173,
            "data": {
                "url": "20020 Diagnosis & management of Kawasaki disease 1.0.003.jpeg"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 174,
            "data": {
                "is_heading": 0,
                "text": "Diagnosis and Management of Kawasaki Disease / Document number / 0.5(1)draft"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 175,
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Page  of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 176,
            "data": {
                "is_heading": 0,
                "text": "Diagnosis and Management of Kawasaki Disease / Document number / 0.5(1)draft"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 177,
            "data": {
                "is_heading": 1,
                "text": "Appendix 2: Preliminary equality analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 178,
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Diagnosis and Management of Kawasaki Disease (please tick all that apply)"
            }
        },
        {
            "type": "table",
            "sequence_num": 179,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2612 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing policy"
                    },
                    {
                        "text": "\u2612 A change to the way staff work"
                    },
                    {
                        "text": "\u2612 A new policy"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 180,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "To align the current practices with the dated methods of practice"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "To have improved outcomes in patients with Kawasaki Disease"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Patients and Staff, Updating current practices to improve patient outcomes"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Refer to Pages 1 and 2"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 181,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Dr Sucharita Ghosh"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Paediatric Registrar"
                    },
                    {
                        "text": "13 July 2020"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 182,
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Page  of"
            }
        }
    ]
}